Printer Friendly

HCA Healthcare sees FY18 EPS $8.50-$9.00 including items, consensus $7.52.

Sees FY18 revenue $45B-$46B, consensus $45.32B. Sees FY18 adjusted EBITDA $8.45B-$8.75B. Sees FY18 CapEx approximately $3.5B. 2018 guidance for EPS includes an estimated $50M income tax benefit, or 14c per diluted share, for excess tax benefits related to employee equity award settlements recorded as a component of the provision for income taxes. 2018 guidance assumes the sale of the Company's Oklahoma facilities closing during the first quarter. These facilities had annual revenues of approximately $1B and Adjusted EBITDA of approximately $180M in 2017. 2018 guidance includes an estimated impact of $1.35 EPS related to the Tax Cuts and Jobs Act.

COPYRIGHT 2018 The Fly
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:The Fly
Date:Jan 30, 2018
Previous Article:HCA Healthcare initiates 35c per share dividend.
Next Article:AK Steel CEO 'enthusiastic' about 2018 key end-use market demand.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters